Remedy Plan
Gaithersburg, MD · Biotechnology, Healthcare · 9 employees
Remedy Plan Therapeutics is a privately-held, clinical-stage pharmaceutical company developing novel, hyperbolic NAMPT inhibitors. NAMPT is an enzyme that controls how cells use energy and is core to human biology. It is dysregulated in more than 20 diseases spanning oncology, autoimmunity, and metabolic disorders. Previous efforts by others to inhibit NAMPT activity resulted in severe on-target t
Funding history
- Venture - Series Unknown — $18.0M — May 2025
- Venture - Series Unknown — $19.1M — Aug 2023
- Venture - Series Unknown — $5.2M — Dec 2019
- Seed — $1.5M — Nov 2018
Recent signals
- May 13, 2025: Raised $18.0M in Venture - Series Unknown
- Aug 10, 2023: Raised $19.1M in Venture - Series Unknown
- Dec 02, 2019: Raised $5.2M in Venture - Series Unknown
- Nov 20, 2018: Raised $1.5M in Seed
See plans & pricing → Track Remedy Plan’s funding, hiring, and signals — with verified contacts — on Fundz.